---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-000642"
form_type: "8-K"
ticker: "GNLX"
cik: "0001231457"
company_name: "GENELUX Corp"
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T05:32:29.068850+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Genelux prices $10.5M underwritten offering of 3M shares at $3.50/share

## Summary
- Gross proceeds of $10.5M from 3,000,000 shares at $3.50 per share; closing expected March 26, 2025.
- Underwriter receives warrant to purchase 120,000 shares at $4.20 per share, exercisable after 180 days.
- Proceeds for working capital and continued clinical development of Olvi-Vec.
- Titan Partners Group acting as sole bookrunner; offering under effective shelf registration S-3.
- Shares sold in registered direct offering; underwriting discounts and expenses not yet disclosed.

## SEC filing metadata
- accession: 0001641172-25-000642
- form_type: 8-K
- ticker: GNLX
- cik: 0001231457
- company_name: GENELUX Corp
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1231457/000164117225000642/0001641172-25-000642-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1231457/000164117225000642/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-000642
- JSON: https://secwatch.observer/filing/0001641172-25-000642.json
- Plain text: https://secwatch.observer/filing/0001641172-25-000642.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.